IV selexipag can be used as a bridging therapy

PHA Canada
Jun 9, 2025
1 min read

Pulmonary arterial hypertension patients who take selexipag normally take it orally (as a pill). Sometimes, though, this is temporarily impossible. People might be unable to swallow or have other medical conditions that interfere with their ability to take pills. A small study looked at whether temporarily giving selexipag as an intravenous infusion was safe and effective. They found that it was.

Read the Therapeutics and Clinical Risk Management paper

Recent Posts

Promising results for drug candidate CS1

This press release reports that over the 12 months of their Expanded Access Program enrolling ten patients, the majority of patients with pulmonary arterial hypertension who completed treatment with d

Using sotatercept off-label in children

Clinical trials for sotatercept didn't include children, so any pediatric use is off-label. This study, conducted at one children's hospital in San Diego, evaluated sotatercept in 7 pediatric patients

Phase 1 trial of treprostinil prodrug patch succeeds

A 9-participant phase 1 clinical trial used a patch to deliver a prodrug of treprostinil (a prodrug is something that is metabolized into the drug in question inside the body). Each participant wore a

Comments